Literature DB >> 30767689

C9orf72-dependent lysosomal functions regulate epigenetic control of autophagy and lipid metabolism.

Yang Liu1, Jiou Wang1.   

Abstract

Cellular adaption to nutrient stress is exquisitely regulated, and its dysregulation could underlie human diseases including neurodegeneration. C9orf72 is linked to the most common forms of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) as well as rare cases of other neurological disorders. Recent studies have implicated C9orf72 functions in the autophagy-lysosome pathway, but the exact roles of C9orf72 remain unclear. We found that C9orf72 is required for the lysosomal targeting and degradation of CARM1, which is an important epigenetic regulator of macroautophagy/autophagy and lipid metabolism. In cells with C9orf72 deficiency including those derived from ALS-FTD patients, CARM1 is abnormally accumulated especially under glucose starvation stress, leading to dysregulated autophagy and lipid metabolism. These findings suggest that C9orf72 is a key regulator in the negative feedback control of the autophagy-lysosome pathway during nutrient stress responses.

Entities:  

Keywords:  ALS; C9orf72; CARM1; FTD; NOX2; autophagy; fatty acid; lipid metabolism; lysosome

Mesh:

Substances:

Year:  2019        PMID: 30767689      PMCID: PMC6526819          DOI: 10.1080/15548627.2019.1580106

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  1 in total

1.  A C9orf72-CARM1 axis regulates lipid metabolism under glucose starvation-induced nutrient stress.

Authors:  Yang Liu; Tao Wang; Yon Ju Ji; Kenji Johnson; Honghe Liu; Kaitlin Johnson; Scott Bailey; Yongwon Suk; Yu-Ning Lu; Mingming Liu; Jiou Wang
Journal:  Genes Dev       Date:  2018-10-26       Impact factor: 11.361

  1 in total
  7 in total

1.  Chemical chaperones targeted to the endoplasmic reticulum (ER) and lysosome prevented neurodegeneration in a C9orf72 repeat expansion drosophila amyotrophic lateral sclerosis (ALS) model.

Authors:  Salome Azoulay-Ginsburg; Michela Di Salvio; Michal Weitman; Michal Afri; Sara Ribeiro; Simon Ebbinghaus; Gianluca Cestra; Arie Gruzman
Journal:  Pharmacol Rep       Date:  2021-03-04       Impact factor: 3.024

2.  The contribution of proteasomal impairment to autophagy activation by C9orf72 poly-GA aggregates.

Authors:  Mei Pu; Yusi Tai; Luyang Yuan; Yu Zhang; Huijie Guo; Zongbing Hao; Jing Chen; Xinming Qi; Guanghui Wang; Zhouteng Tao; Jin Ren
Journal:  Cell Mol Life Sci       Date:  2022-08-29       Impact factor: 9.207

3.  Neutral Lipid Cacostasis Contributes to Disease Pathogenesis in Amyotrophic Lateral Sclerosis.

Authors:  James C Dodge; Elizabeth H Jensen; Jinlong Yu; S Pablo Sardi; Allison R Bialas; Tatyana V Taksir; Dinesh S Bangari; Lamya S Shihabuddin
Journal:  J Neurosci       Date:  2020-10-13       Impact factor: 6.167

Review 4.  Metabolomics: A Tool to Understand the Impact of Genetic Mutations in Amyotrophic Lateral Sclerosis.

Authors:  Débora Lanznaster; Charlotte Veyrat-Durebex; Patrick Vourc'h; Christian R Andres; Hélène Blasco; Philippe Corcia
Journal:  Genes (Basel)       Date:  2020-05-11       Impact factor: 4.096

5.  Sterol auto-oxidation adversely affects human motor neuron viability and is a neuropathological feature of amyotrophic lateral sclerosis.

Authors:  James C Dodge; Jinlong Yu; S Pablo Sardi; Lamya S Shihabuddin
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

6.  Reduced mitochondrial D-loop methylation levels in sporadic amyotrophic lateral sclerosis.

Authors:  Andrea Stoccoro; Adam R Smith; Lorena Mosca; Alessandro Marocchi; Francesca Gerardi; Christian Lunetta; Cristina Cereda; Stella Gagliardi; Katie Lunnon; Lucia Migliore; Fabio Coppedè
Journal:  Clin Epigenetics       Date:  2020-09-11       Impact factor: 6.551

Review 7.  C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels.

Authors:  Jimmy Beckers; Arun Kumar Tharkeshwar; Philip Van Damme
Journal:  Autophagy       Date:  2021-02-26       Impact factor: 16.016

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.